Tg Therapeutics logo

Tg Therapeutics Share Price Today

(NASDAQ: TGTX)

Tg Therapeutics share price is $37.35 & ₹3,184.93 as on 5 Apr 2025, 2.30 'hrs' IST

$37.35

-1.99

(-5.06%)

Market is closed - opens 7 PM, 07 Apr 2025

View live Tg Therapeutics share price in Dollar and Rupees. Guide to invest in Tg Therapeutics stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Tg Therapeutics, along with analyst recommendations, forecasts, and comprehensive financials.

Tg Therapeutics share price movements

  • Today's Low: $36.61
    Today's High: $38.68

    Day's Volatility :5.35%

  • 52 Weeks Low: $12.93
    52 Weeks High: $43.32

    52 Weeks Volatility :70.15%

Tg Therapeutics (TGTX) Returns

PeriodTg Therapeutics IncSector (Health Care)Index (Russel 2000)
3 Months
40.5%
3.0%
0.0%
6 Months
84.61%
-5.6%
0.0%
1 Year
162.79%
-0.1%
0.0%
3 Years
324.84%
2.7%
-12.3%

Tg Therapeutics (TGTX) Key Statistics

in dollars & INR

Previous Close
$39.34
Open
$37.94
Today's High
$38.68
Today's Low
$36.6096
Market Capitalization
$6.2B
Today's Volume
$3.1M
52 Week High
$43.32
52 Week Low
$12.93
Revenue TTM
$329.0M
EBITDA
$42.0M
Earnings Per Share (EPS)
$0.15
PE Ratio
262.27
Profit Margin
7.11%
Quarterly Earnings Growth YOY
-0.97%
Return On Equity TTM
12.22%

How to invest in Tg Therapeutics Stock (TGTX) from India?

It is very easy for Indian residents to invest directly in Tg Therapeutics from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Tg Therapeutics stock in both Indian Rupees (INR) and US Dollars (USD). Search for Tg Therapeutics or TGTX on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Tg Therapeutics or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Tg Therapeutics shares which would translate to 0.023 fractional shares of Tg Therapeutics as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Tg Therapeutics, in just a few clicks!

Returns in Tg Therapeutics (TGTX) for Indian investors in Rupees

The Tg Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Tg Therapeutics investment value today

Current value as on today

₹2,51,914

Returns

₹1,51,914

(+151.91%)

Returns from Tg Therapeutics Stock

₹1,49,499 (+149.5%)

Dollar Returns

₹2,415 (+2.42%)

Indian investors sentiment towards Tg Therapeutics (TGTX)

23.64%

Period: Mar 7, 2025 to Apr 6, 2025. Change in 30 Days versus previous period

Investment in Tg Therapeutics Shares from India has grown by 23.64% over the past 30 days, indicating increased transactional activity.

65%

Period: Mar 7, 2025 to Apr 6, 2025. Change in 30 Days versus previous period

Search interest for Tg Therapeutics Stock from India on INDmoney has increased by 65% in the last 30 days, reflecting an upward trend in search activity.

Global Institutional Holdings in Tg Therapeutics

  • BlackRock Inc

    13.94%

  • Vanguard Group Inc

    9.93%

  • State Street Corp

    5.86%

  • Geode Capital Management, LLC

    2.03%

  • Pictet Asset Manangement SA

    1.78%

  • Soleus Capital Management, L.P.

    1.71%

Analyst Recommendation on Tg Therapeutics

Buy

    80%Buy

    13%Hold

    6%Sell

Based on 15 Wall street analysts offering stock ratings for Tg Therapeutics(by analysts ranked 0 to 5 stars)

Based on 15 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
12
12
12
Hold
2
2
2
Sell
1
1
1

Analyst Forecast on Tg Therapeutics Stock (TGTX)

What analysts predicted

Upside of 15.13%

Target:

$43.00

Current:

$37.35

Insights on Tg Therapeutics Stock (Ticker Symbol: TGTX)

  • Price Movement

    In the last 1 month, TGTX stock has moved up by 11.8%
  • Increasing Revenue

    Revenue is up for the last 5 quarters, 43.97M → 108.18M (in $), with an average increase of 19.8% per quarter
  • Increasing Net Profit

    Netprofit is up for the last 2 quarters, 3.88M → 23.33M (in $), with an average increase of 83.4% per quarter

Tg Therapeutics Technicals Summary

Sell

Neutral

Buy

Tg Therapeutics is currently in a neutral trading position according to technical analysis indicators.

Tg Therapeutics (TGTX) Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Tg Therapeutics Inc logo
2.34%
84.61%
162.79%
324.84%
289.5%
Regeneron Pharmaceuticals, Inc. logo
-18.02%
-38.69%
-34.93%
-17.35%
19.19%
Beone Medicines Ltd logo
8.93%
8.76%
76.51%
34.47%
88.26%
Vertex Pharmaceuticals Incorporated logo
-3.2%
7.89%
19.74%
72.69%
93.87%
Alnylam Pharmaceuticals, Inc. logo
12.48%
-1.73%
68.01%
60.42%
135.35%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Tg Therapeutics Inc logo
262.27
262.27
0.0
1.05
0.12
0.06
NA
1.54
Regeneron Pharmaceuticals, Inc. logo
15.92
15.92
0.91
42.18
0.16
0.07
0.01
273.57
Beone Medicines Ltd logo
NA
NA
NA
1.45
-0.19
-0.06
NA
31.22
Vertex Pharmaceuticals Incorporated logo
32.84
NA
1.33
18.04
-0.03
0.13
NA
63.87
Alnylam Pharmaceuticals, Inc. logo
NA
NA
-0.49
0.96
-15.01
-0.03
NA
0.52
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Tg Therapeutics Inc logo
Buy
$6.2B
289.5%
262.27
7.11%
Regeneron Pharmaceuticals, Inc. logo
Buy
$66.8B
19.19%
15.92
31.07%
Beone Medicines Ltd logo
NA
$30.9B
88.26%
NA
-16.92%
Vertex Pharmaceuticals Incorporated logo
Buy
$124.3B
93.87%
32.84
-4.86%
Alnylam Pharmaceuticals, Inc. logo
Buy
$33.9B
135.35%
NA
-12.37%

About Tg Therapeutics

TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell mediated diseases in the United States and internationally. It provides BRIUMVI, an anti-CD20 monoclonal antibody for the treatment of adult patients with relapsing forms of multiple sclerosis (RMS), including clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease in adults. The company's development pipeline comprises Ublituximab IV, glycoengineered anti-CD20 mAb for the treatment of relapsing MS; TG-1701 is an orally available and covalently bound Bruton's tyrosine kinase (BTK) inhibitor that exhibits selectivity to BTK in vitro kinase screening; and TG-1801, a bispecific CD47 and CD19 antibody. Its research pipeline includes various investigational medicines. The company has license agreements with LFB Biotechnologies S.A.S; GTC Biotherapeutics; LFB/GTC LLC; Ildong Pharmaceutical Co. Ltd.; Rhizen Pharmaceuticals, S A. for the development and commercialization of umbralisib; Jiangsu Hengrui Medicine Co.; and Novimmune SA, as well as collaboration agreement with Checkpoint Therapeutics, Inc. for the development and commercialization of anti-PD-L1 and anti-GITR antibody research programs in the field of hematological malignancies. The company was incorporated in 1993 and is based in Morrisville, North Carolina.
Organization
Tg Therapeutics
Employees
338
CEO
Mr. Michael S. Weiss Esq.
Industry
Health Technology

Management People of Tg Therapeutics

NameTitle
Mr. Michael S. Weiss Esq.
Chairman, CEO & President
Ms. Jenna Bosco
Senior Vice President of Corporate Communications
Mr. Adam Waldman
Chief Commercialization Officer

Important FAQs about investing in TGTX Stock from India :

What is Tg Therapeutics share price today?

Tg Therapeutics share price today stands at $37.35, Open: $37.94 ; Previous Close: $39.34 ; High: $38.68 ; Low: $36.61 ; 52 Week High: $43.32 ; 52 Week Low: $12.93.

The stock opens at $37.94, after a previous close of $39.34. The stock reached a daily high of $38.68 and a low of $36.61, with a 52-week high of $43.32 and a 52-week low of $12.93.

Can Indians buy Tg Therapeutics shares?

Yes, Indians can invest in the Tg Therapeutics (TGTX) from India.

With INDmoney, you can buy Tg Therapeutics at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Tg Therapeutics at zero transaction cost.

How can I buy Tg Therapeutics shares from India?

It is very easy to buy Tg Therapeutics from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Tg Therapeutics (TGTX) be purchased?

Yes, you can buy fractional shares of Tg Therapeutics with INDmoney app.

What are the documents required to start investing in Tg Therapeutics stocks?

To start investing in Tg Therapeutics, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Tg Therapeutics Stock (TGTX)?

Today’s highest price of Tg Therapeutics (TGTX) is $38.68.

Today’s lowest price of Tg Therapeutics (TGTX) is $36.61.

What is today's market capitalisation of Tg Therapeutics?

Today's market capitalisation of Tg Therapeutics TGTX is 6.2B

What is the 52 Week High and Low Range of Tg Therapeutics Stock (TGTX)?

  • 52 Week High

    $43.32

  • 52 Week Low

    $12.93

What are the historical returns of Tg Therapeutics (TGTX)?

  • 1 Month Returns

    2.34%

  • 3 Months Returns

    84.61%

  • 1 Year Returns

    162.79%

  • 5 Years Returns

    289.5%

Who is the Chief Executive Officer (CEO) of Tg Therapeutics ?

Mr. Michael S. Weiss Esq. is the current Chief Executive Officer (CEO) of Tg Therapeutics.